Articles by Stephanie Sutton - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Stephanie Sutton

Merck KGaA Announces Job Cuts

Apr 27, 2012

Merck KGaA has revealed further details about its previously announced restructuring program, including plans to eliminate approximately 580 jobs.

GSK Divests OTC Brands Worth $264.7 Million

Apr 26, 2012

GlaxoSmithKline has reached an agreement to divest certain over-the-counter brands in selected territories to South Africa's Aspen Pharmacare Holdings for approximately $264.7 million.

EC Offers Cash Prize for Vaccine Stability

Apr 25, 2012

The European Commission is offering a EUR 2-million ($2.64 million) inducement prize to encourage innovation in the area of cold-chain logistics and vaccine stability.

Illumina Urges Shareholders to Reject Roche Offer

Apr 17, 2012

Illumina has sent a fourth letter to shareholders urging them to reject Roche?s offer of $51 per share, which Illumina claims is opportunistic and undervaluing the company. In addition, the letter urges shareholders to vote against the candidates that Roche has nominated for election to Illumina?s board of directors. The election will take place at the board?s general meeting on Apr. 18, 2012.

UK Invests in Regenerative Medicine

Apr 10, 2012

An initiative in the UK will invest £75 million ($120.2 million) into translational science, with the aim of transforming biological understanding into clinical impacts that will benefit patients and the UK economy.

Europe Adopts Transparency Guideline

Apr 3, 2012

The European Medicines Agency (EMA) has released guidance that outlines a European-wide approach for dealing with transparency and access to information included in marketing authorization applications.

Court Dismisses AstraZeneca's FDA Lawsuit

Apr 3, 2012

A US court has denied AstraZeneca?s request for a preliminary injunction against FDA.

GSK Launches UK Apprenticeship Program

Mar 20, 2012

GlaxoSmithKline (GSK) is launching a new program that will create apprenticeships in several areas including manufacturing and R&D at the company’s United Kingdom sites.

EMA Announces Electronic Applications Pilot Program

Mar 20, 2012

The European Medicines Agency (EMA) has launched a pilot program for submitting centralized marketing authorization applications electronically.

ADVERTISEMENT

ADVERTISEMENT

Click here